Finn Patrick John 4

What Happened

• Finn Patrick John, President and Chief Operating Officer of Twist Bioscience (TWST), sold 4,160 shares on 2026-05-21 at $53.26 per share, generating proceeds of approximately $221,549. The transaction is reported as a sale (S) and was executed to satisfy tax-withholding obligations related to vesting restricted stock units (RSUs).

Key Details

• Transaction date: 2026-05-21; Filing date: 2026-05-26 (appears later than the typical 2-business-day Form 4 deadline).
• Price and amount: 4,160 shares at $53.26 per share; proceeds ≈ $221,549.
• Shares owned after the transaction: not specified in the provided summary filing.
• Footnote: The sale was a "sell to cover" required by the issuer to satisfy tax withholding on vested RSUs (footnote F1). These mandated sales are not discretionary trades by the insider.
• Transaction code: S = Sale; related to tax withholding (F).

Context

• This was a routine sell-to-cover tied to RSU vesting, which companies commonly use to meet tax obligations. Such transactions are generally administrative and don’t necessarily indicate the insider’s view of the company’s prospects; purchases tend to be more informative about insider sentiment.